Measuring disease modification in Alzheimer's disease.
Cummings
Jeffrey L
JL
D000544:Alzheimer Disease / Q000175:diagnosis / Q000188:drug therapy*; D000818:Animals; D015415:Biomarkers / Q000378:metabolism; D001921:Brain / Q000187:drug effects / Q000469:parasitology; D002986:Clinical Trials as Topic; D003952:Diagnostic Imaging; D004195:Disease Models, Animal; D006801:Humans; D008609:Mental Status Schedule; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D018697:Nootropic Agents / Q000627:therapeutic use*; D016896:Treatment Outcome; D014481:United States; D014486:United States Food and Drug Administration
D015415:Biomarkers; D018696:Neuroprotective Agents; D018697:Nootropic Agents